Fortress Biotech DSO Ratio 2011-2026 | FBIO

Annual DSO Ratio Fortress Biotech

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
115	80.5	93.8	124	113	161	144	103	33.8	192	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
192	33.8	116

Quarterly DSO Ratio Fortress Biotech

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
122	87	93.6	98.1	-	65.9	62.1	87.6	-	32.5	116	205	-	158	145	104	-	125	117	171	-	230	209	116	-	126	134	134	55.8	97	73.6	102	13.1	12.6	14	8	17.3	338	74.9	127	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
338	8	108

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	2.94 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	29	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	99.7	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	39.1	$ 32.59	-6.89 %	$ 877 M	USA
Affimed N.V. AFMD	31.4	-	-34.95 %	$ 21.5 M	Germany
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
IMV IMV	2.16 K	-	-	$ 13.1 M	Canada
Autolus Therapeutics plc AUTL	58.2	$ 1.7	3.03 %	$ 452 M	Britain
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	198	$ 0.86	-1.42 %	$ 143 M	USA
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	400	$ 2.8	7.28 %	$ 262 M	Israel
Anika Therapeutics ANIK	76.5	$ 14.88	-0.93 %	$ 213 M	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Incyte Corporation INCY	66.6	$ 97.16	-0.26 %	$ 19 B	USA
Ionis Pharmaceuticals IONS	20.5	$ 75.56	-0.29 %	$ 12.1 B	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.4	-1.16 %	$ 5.6 M	Israel
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	559	$ 1.61	2.55 %	$ 189 M	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA